Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis

Marta Casal Moura1, Fernando C Fervenza2, Ulrich Specks1

  • 1Department of Medicine, Division of Pulmonary and Critical Care, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.

Insights

Chronic kidney disease changes on biopsy predict outcomes in ANCA-associated vasculitis with glomerulonephritis (AAV-GN). The Mayo Clinic Chronicity Score (MCCS) effectively predicts kidney failure and survival, aiding clinical decisions.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Kidney biopsy is crucial for prognostication in ANCA-associated vasculitis with glomerulonephritis (AAV-GN).
  • The impact of chronic histological changes on renal outcomes in AAV-GN requires further determination.

Purpose of the Study:

  • To validate and evaluate the Mayo Clinic Chronicity Score (MCCS) for outcome prediction in AAV-GN.
  • To assess the independent predictive value of chronic kidney changes on renal function and survival.

Main Methods:

  • Retrospective cohort study of 329 myeloperoxidase (MPO)- or proteinase 3 (PR3)-ANCA-positive patients with AAV and active renal disease.
  • Application and validation of the Mayo Clinic Chronicity Score (MCCS) using kidney biopsy data.
  • Analysis of correlations between MCCS grades, renal function (eGFR), and clinical outcomes (kidney failure, death).

Main Results:

  • MCCS grades significantly correlated with impaired renal function at presentation (P < 0.0001).
  • Higher MCCS scores were associated with lower eGFR, reduced renal recovery, and increased risk of kidney failure and death (P < 0.0001).
  • MCCS effectively stratified renal outcomes and identified a cutoff (MCCS ≥4) for kidney failure prediction.

Conclusions:

  • Chronic changes on kidney histology independently predict renal function, outcomes, and treatment response in AAV-GN.
  • The MCCS is a valuable tool for prognostic assessment and clinical decision-making in AAV-GN.
  • Histological chronicity assessment aids in predicting kidney failure risk.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
312
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
97
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
146
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
176
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
332
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
184